- Nachrichtendetail
-
20.06.2024 14:10:15 - dpa-AFX: *J&J : TREMFYA PHASE 3 CROHN'S DISEASE STUDY ACHIEVES ALL PRIMARY AND SECONDARY ENDPOINTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
JOHNSON + JOHNSON DL 1 | 853260 | Xetra | 136,400 | 10.07.24 16:37:11 | +1,160 | +0,86% | 136,560 | 136,680 | 135,980 | 135,240 |
